Showing results (41-50 of 97) with videos related to
Sort By:
Pageof 10
Open Biology|April 9, 2019
Emerging microRNA biomarkers for colorectal cancer diagnosis and prognosisBing Chen, Zijing Xia, Ya-Nan Deng, et al.Open Biology|October 13, 2017
Protein SUMOylation modification and its associations with diseaseYanfang Yang, Yu He, Xixi Wang, et al.Journal of Ethnopharmacology|May 1, 2026
Diosgenin alleviates hepatic fibrosis via PI3K/Akt/mTOR mediated fatty acid metabolic reprogramming and NF-κB activationYuanrong Shi, Ye Zhang, Dan Liu, et al.Molecular Medicine Reports|July 6, 2017
In vitro anticancer effects of two novel phenanthroindolizidine alkaloid compounds on human colon and liver cancer cellsJingjing Liu, Yu He, Dan Zhang, et al.Oncology Reports|January 13, 2018
A double-edged function of DDX3, as an oncogene or tumor suppressor, in cancer progression (Review)Yu He, Dan Zhang, Yanfang Yang, et al.Electrophoresis|June 20, 2019
MS-based strategies for identification of protein SUMOylation modificationZenghua Sheng, Xixi Wang, Yanni Ma, et al.Cancer Letters|December 9, 2008
Prokaryotic expression, purification of a new tumor-relative protein FAM92A1-289 and its characterization in renal cell carcinomaShufang Liang, Fengming Gong, Xinyu Zhao, et al.Omics : a Journal of Integrative Biology|February 12, 2009
Quantitative proteomic analysis of HepG2 cells treated with quercetin suggests IQGAP1 involved in quercetin-induced regulation of cell proliferation and migrationJin Zhou, Shufang Liang, Li Fang, et al.International Immunopharmacology|October 10, 2025
Arsenic trioxide enhances the inhibitory effect of lenvatinib on hepatocellular carcinoma through HMOX1-mediated ferroptosisShufang Liang, Guokai Huang, Meihuan Fu, et al.European Journal of Medicinal Chemistry|February 14, 2024
Novel inhibitors targeting the PGK1 metabolic enzyme in glycolysis exhibit effective antitumor activity against kidney renal clear cell carcinoma in vitro and in vivoYu He, Yinheng Luo, Lan Huang, et al.Pageof 10